Gianotti N - Search Results

1

Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.

Guffanti M, De Pascalis CR, Seminari E, Fusetti G, Gianotti N, Bassetti D, Galli A, Castagna A, Lazzarin A. Guffanti M, et al. Among authors: gianotti n. AIDS. 2003 Dec 5;17(18):2669-71. doi: 10.1097/00002030-200312050-00017. AIDS. 2003. PMID: 14685066

2

The thymic hormones in the treatment of immune deficiency related to HIV infection.

Gianotti N, Finazzi R, Uberti Foppa C, Danise A, Migone T, Lazzarin A. Gianotti N, et al. Pharmacol Res. 1992 Sep;26 Suppl 2:62-3. doi: 10.1016/1043-6618(92)90600-g. Pharmacol Res. 1992. PMID: 1409328 No abstract available.

3

Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with tuberculous meningitis.

Scarpellini P, Racca S, Cinque P, Delfanti F, Gianotti N, Terreni MR, Vago L, Lazzarin A. Scarpellini P, et al. Among authors: gianotti n. AIDS. 1995 Aug;9(8):895-900. doi: 10.1097/00002030-199508000-00010. AIDS. 1995. PMID: 7576324

4

Thallium-201 single photon emission computed tomography in the management of contrast-enhancing brain lesions in a patient with AIDS.

Gianotti N, Marenzi R, Messa C, Terreni MR, Rocca A, Castagna A. Gianotti N, et al. Clin Infect Dis. 1996 Jul;23(1):185-6. doi: 10.1093/clinids/23.1.185. Clin Infect Dis. 1996. PMID: 8816155 No abstract available.

5

Diagnosis of toxoplasmic encephalitis in HIV-infected patients.

Gianotti N, Cinque P, Castagna A, Novati R, Moro M, Lazzarin A. Gianotti N, et al. AIDS. 1997 Oct;11(12):1529-30. AIDS. 1997. PMID: 9342082 No abstract available.

6

Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease.

Uberti-Foppa C, Lillo F, Terreni MR, Puglisi A, Guffanti M, Gianotti N, Lazzarin A. Uberti-Foppa C, et al. Among authors: gianotti n. Chest. 1998 Apr;113(4):919-23. doi: 10.1378/chest.113.4.919. Chest. 1998. PMID: 9554626

7

Prevalence of mutation associated to resistance with nucleoside analogues in a cohort of naïve HIV-1 positive subjects during the period 1984-1997.

Tambussi G, Boeri E, Carrera P, Gianotti N, Lazzarin A. Tambussi G, et al. Among authors: gianotti n. J Biol Regul Homeost Agents. 1998;12(1-2 Suppl):32-4. J Biol Regul Homeost Agents. 1998. PMID: 9689577

8

Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients.

Uberti-Foppa C, De Bona A, Morsica G, Guffanti M, Gianotti N, Boeri E, Lazzarin A. Uberti-Foppa C, et al. Among authors: gianotti n. AIDS. 1999 Jan 14;13(1):140-1. AIDS. 1999. PMID: 10207560 No abstract available.

9

The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs.

Gianotti N, Moretti F, Tambussi G, Capiluppi B, Ferrari M, Lazzarin A. Gianotti N, et al. J Biol Regul Homeost Agents. 1999 Jul-Sep;13(3):158-62. J Biol Regul Homeost Agents. 1999. PMID: 10560749

10

Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner.

Morsica G, Sitia G, Bernardi MT, Tambussi G, Novati R, De Bona A, Gianotti N, Lazzarin A. Morsica G, et al. Among authors: gianotti n. Scand J Infect Dis. 2001;33(2):116-20. doi: 10.1080/003655401750065490. Scand J Infect Dis. 2001. PMID: 11233845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters